Novo Integrated Sciences, Inc.: Nasdaq/NYSE listing notice — Novo Integrated Sciences receives Nasdaq non-compliance notice for minimum bid price

Novo Integrated Sciences, Inc.

Nasdaq notified NVOS on Feb 9, 2024 that it failed to maintain minimum bid of $1.00 per share for 30 consecutive business days.
Non-compliance period: Dec 27, 2023 to Feb 8, 2024; stock continues trading on Nasdaq under symbol NVOS.
Company has 180 days, until Aug 7, 2024, to regain compliance by closing at $1.00+ for 10 consecutive business days.
If not cured by Aug 7, an additional 180 days may be granted if all other listing requirements are met.
Failure to regain compliance could lead to delisting; company intends to monitor and consider available options.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Novo Integrated Sciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

February 9, 2024, Novo Integrated Sciences, Inc., a Nevada corporation (the “Company”), received a notification letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq. Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency con

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-24-006885

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.